1/3/24-Medication for Addiction Treatment for Opioid Use Disorder-Part 2

Presentation Resources:

-Patient Instructions: Take Home Suboxone. Retrieved from:
https://patienteduc.fraserhealth.ca/file/take-home-suboxone- buprenorphine-naloxone-instruc-420867.pdf

-ED Initiated Buprenorphine. Retrieved from:
https://www.drugabuse.gov/nidamed-medical-health- professionals/discipline-specific-resources/initiating-buprenorphine- treatment-in-emergency-department

-https://www.fda.gov/media/108382/download

-Integrating Buprenorphine Treatment for Opioid Use Disorder in Primary Care:
Implementation Manual. Retrieved from: https://ciswh.org/wp- content/uploads/2017/06/Buprenorphine-Implementation-Manual-for- Primary-Care-Settings-.pdf

-A Quick Reference Guide for Prescribing Buprenorphine in the Outpatient Setting. Retrieved from: https://ciswh.org/wp- content/uploads/2017/06/Buprenorphine-Implementation-Manual-for- Primary-Care-Settings-.pdf

-Alford DP Arch Intern Med. 2011. Five Year Experience with Collaborative Care of Opioid Addicted Patients using Buprenorphine in Primary Care. Mar 14;171(5):425-31. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3059544/

-Carroll KM, Weiss RD. Am J Psychiatry. 2016 Dec 16. The role of behavioral interventions in buprenorphine maintenance treatment: A review.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474206/

-COWS for opioid withdrawal:
http://www.mdcalc.com/cows-score-opiate-withdrawal/

-Dreifuss JA Drug Alcohol Depend. 2013 Jul 1;131(1-2):112-8.
Patient Characteristics Associated with Buprenorphine/Naloxone Treatment Outcome for Prescription Opioid Dependence: Results from a Multisite Study
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638044/

-Evans, et al., Recidivism and mortality after in jail Buprenorphine treatment for opioid use disorder,
(2021), Drug and Alcohol Independence, (NIDA)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852331/

-Liebschutz, J et al. (2014). Buprenorphine treatment for hospitalized, opioid-dependent patients: A randomized clinical trial. JAMA Internal Medicine, 174(8), 1369-1376. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811188/

-Livingston JD, et al. (2011). The effectiveness of interventions for reducing stigma
related to substance use disorders: a systematic review. Addiction, 107, 39-50. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272222/

-Robohm, J.S.( 2017) Training to reduce behavioral health disparities: How do we optimally prepare family medicine residents for practice in rural communities?
International Journal of Psychiatry & Medicine. doi: 10.1177/0091217417730294.
https://journals.sagepub.com/doi/10.1177/0091217417730294?icid=int.sj-full-text.similar-articles.8

-Wakeman, S.E. (2017). Medications for addiction treatment: Changing language to improve care. Journal of Addiction Medicine, 11(1):1-2. doi:
10.1097/ADM.0000000000000275 Abstract Only

-Offering buprenorphine medication to people with opioid use in jail may reduce rearrest
and reconviction (2022).
https://nida.nih.gov/news-events/news-releases/2022/01/offering-buprenorphine-medication-to-people-with-opioid-use-disorder-in-jail-may-reduce-rearrest-and-reconviction#:~:text=%E2%80%9CThough%20this%20study%20was%20done,of%20adequate%20help%20and%20resources.

-Opioid Overdose Deaths
https://michigan.gov and Injury Prevention Center at Univ of Michigan (https://injurycenter.umich.edu/)

-WinStanley, EL, et al. (2022). Patient-reported problems filling buprenorphine prescriptioons and motivations for illicit use.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949336/